Neoleukin Therapeutics Inc NLTX Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Neoleukin Therapeutics Inc (NLTX)
Neoleukin Therapeutics Inc (NLTX) Financials

Neoleukin Therapeutics Inc (NLTX)

3.49

0.00

(0.00%)

Closed 12 December 8:00AM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-27.642	-37.916	-33.611	-61.825	-18.614	-32.475	-41.228	-21.456
Return on Equity (%)	-29.241	-41.209	-36.821	-64.79	-19.992	-36.334	-48.531	-25.908
Return on Invested Capital (%)	-45.732	-52.981	-38.172	-66.054	-20.255	-36.621	-50.289	-39.938
Operating Margin (%)	N/A	N/A	-126.324	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	-126.34	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	4.892	3.339	2.448	3.197	3.948	2.937	1.933	11.967
Earnings Per Share	-1.251	-1.694	-1.064	-1.573	-0.688	-1.249	-1.18	-2.336
Cash Per Share	1.092	1.757	2.592	3.242	3.983	2.931	0.776	9.534
Working Capital Per Share	3.178	3.304	2.444	3.145	3.861	2.785	1.805	11.41
Operating Profit Per Share	N/A	N/A	0.842	N/A	0.162	N/A	N/A	N/A
EBIT Per Share	-1.251	-1.694	-1.064	-1.573	-0.688	-1.249	-1.18	-2.336
EBITDA Per Share	-1.251	-1.694	-1.064	-1.573	-0.688	-1.249	-1.18	-2.336
Free Cash Flow Per Share	-1.227	-1.678	-1.062	-1.561	-0.659	-1.208	-1.189	-2.528

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	23.42M	23.47M	23.54M	38M	42.2M	42.46M	42.65M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	42.65M	N/A	N/A	N/A	N/A	N/A	N/A	13.01M
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	40.7M
Price to Earnings Ratio	-7.45
Price to Sales Ratio	0
Price to Cash Ratio	1.83
Price to Book Ratio	1.45
Dividend Yield	-

Share Statistics

Shares Outstanding	11.66M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Neoleukin Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions